Dr. Harvey is a Fellow of the American College of Clinical Pharmacy and a board certified oncology pharmacist.
Titles and Roles
- Director, Phase I Clinical Trials Section
- Winship Cancer Institute of Emory University
- Associate Professor, Department of Hematology and Medical Oncology
- Emory University School of Medicine
- Oncology Pharmacist
- Phase I Clinical Trials Unit
- Research Program
- Discovery and Developmental Therapeutics
R. Donald Harvey, PharmD, is Associate Professor of Hematology and Medical Oncology at the Winship Cancer Institute of Emory University. Dr. Harvey also serves as director of the Winship Cancer Institute’s Phase I Clinical Trials Unit and Section. He is a Fellow of the American College of Clinical Pharmacy and a Board Certified Oncology Pharmacist.
Dr. Harvey has established an active clinical pharmacology research program in cancer at Emory with the goal of using pharmacokinetic, pharmacodynamic, and other tools to improve individualization of therapy and clinical outcomes. An active principal and co-investigator on multiple trials, he also consults on experimental design of preclinical and clinical studies with a focus on optimizing correlative measures. Specific areas of research interest include agent tolerability and disposition in renal and hepatic impairment, effects of novel immunotherapeutics on hepatic metabolism, and use of therapeutic drug monitoring for anticancer agents.
He is also active nationally and internationally in several cancer and pharmacology professional organizations. Dr. Harvey is also a past President of the Hematology and Oncology Pharmacy Association, an international professional organization.
Dr. Harvey obtained his BS Pharmacy and Doctor of Pharmacy degrees at the University of North Carolina at Chapel Hill (UNC). He completed subsequent training at the University of Kentucky Medical Center and School of Pharmacy and specialized in Hematology/Oncology at UNC, where he was on staff and faculty for 8 years prior to coming to Grady Hospital in Atlanta where he served as a clinical specialist in hematology and oncology and director of the hematology and oncology residency program.
Widely published in peer-reviewed journals, Dr. Harvey’s research interests include the clinical application of pharmacokinetic, pharmacodynamic, and pharmacogenomic data to patient care.